INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

77,304 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$87K
845 sh
Apr 17, 2026Apr 21, 2026
Page 1106 of 1933
← PrevNext →
traded Apr 17, 2026
+4d
SEC Form 4

Evidence

0
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Option exercise · 10b5-1 plan
M—
32.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
846 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$75K
1,168 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
416 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$75K
1,007 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$125K
14.7K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,183 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,268 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,339 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$88K
1,071 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$88K
1,375 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$75K
1,414 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
BL
Bradbury Robyn LChief Financial Officer
CNMCore & Main, Inc.
Derivative conversion · 10b5-1 plan
C—
5,000 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,414 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
LD
Liu DongfangCHIEF MEDICAL OFFICER
NUVBNuvation Bio Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
973 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$75K
1,116 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$75K
1,008 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
845 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,168 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,375 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,494 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,543 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$75K
1,200 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$87K
1,494 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$125K
14.7K sh
Apr 21, 2026Apr 21, 2026
traded Apr 21, 2026
+0dSEC Form 4

Evidence

56
DH
Davis Cynthia HDirector
CIACITIZENS, INC.
Open-market purchase
BUY$453
100 sh
Mar 25, 2026Apr 20, 2026
traded Mar 25, 2026
+26dSEC Form 4

Evidence

50
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Open-market sale
SELL$363K
600 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

50
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Open-market purchase
BUY$4.00M
235.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

47
BS
Bolton SheryleDirector
TIVCValion Bio, Inc.
Open-market purchase
BUY$10K
10.0K sh
Apr 15, 2026Apr 20, 2026
traded Apr 15, 2026
+5dSEC Form 4

Evidence

44
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$2.42M
28.0K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

41
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$875K
10.0K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

41
RN
Rogers Mark NEVP & General Counsel
AMKRAMKOR TECHNOLOGY, INC.
Open-market sale
SELL$297K
5,000 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

38
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$133K
1,500 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

38
KS
Karmiri StefaniaCorporate Secretary
ESEAEUROSEAS LTD.
Open-market sale
SELL$18K
250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

37
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$976K
11.4K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

36
LM
Lichtman MosheDirector
VLNValens Semiconductor Ltd.
Open-market sale
SELL$5,513
3,750 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence